期刊文献+

BTNL2基因多态性与广东汉族女性乳腺癌易感性的相关性研究 被引量:3

Association of single nucleotide polymorphisms in BTNL2 gene with susceptibility of breast cancer in Guangdong women of Han Nationality
下载PDF
导出
摘要 目的探讨位于基因BTNL2(butyrophilin-like2)位点chr6-32478813和chr6-32470723的单核苷酸多态性(single nucleotide polymorphisms,SNP)与广东汉族女性乳腺癌易感性的关系。方法采用MassARRAY-IPLEX SNP分型技术,以南方医科大学南方医院的216例广东汉族女性乳腺癌患者及216例同期女性健康体检者为研究对象,对以上2个多态性位点进行基因分型,利用χ2检验统计分析病例组和对照组的基因型频率有无差异,非条件Logistic回归计算比数比(odds ratio,OR)和95%可信区间(confidence interval,CI),由此评价这两个位点多态性与乳腺癌的相关性。随后,将病例组按雌激素受体(estrogen receptor,ER)和孕激素受体(progesterone receptor,PR)免疫组化结果的不同进行进一步的分层分析。结果位点chr6-32478813和chr6-32470723基因型分布频率在病例-对照分组分析中无统计学差异(P>0.05);而进一步的分析发现这两位点的基因型分布频率在ER阴性(-)与ER阳性(+)乳腺癌分组中有一定的差别,但统计学意义不显著;在PR阴性(-)与PR阳性(+)分组中,差异有统计学意义(P<0.05),携带杂合基因型(chr6-32478813,CT;chr6-32470723,GA)的个体更倾向于PR(-)乳腺癌(OR=0.53,95%CI:0.29~0.94,P=0.028;OR=0.44,95%CI:0.19~0.99,P=0.043)。结论 BTNL2基因chr6-32478813和chr6-32470723位点多态性与乳腺癌患病风险均无明显相关性,但两位点的杂合基因型均与乳腺癌组织PR阴性(-)明显相关。 Objective To establish whether the single nucleotide polymorphisms(SNPs) in gene BTNL2 are associated with susceptibility of breast cancer in Guangdong women of Han Nationality. Methods The polymorphisms of two SNPs(chr6-32478813 and chr6-32470723) in gene BTNL2 were analyzed in 216 breast cancer patients and 216 healthy controls that were collected coinstantaneously from Nanfang Hospital of Southern Medical University via MassARRAY -IPLEX platform. The genotype frequencies were analyzed by Chi-square test between case and control groups. Unconditional Logistic regression analysis for calculating odds ratio(OR) and 95% confidence interval(95% CI) was carried through to analyze the associations between the susceptibility of breast cancer and genotypes and then additional analysis was carried upon the immunohistochemical results of estrogen receptor(ER) and progesterone receptor(PR). Results The genotype frequencies were not significantly different between case and control groups for both chr6-32478813 and chr6-32470723(P 0.05). Further analysis indicated the genotype frequencies of these two sites had difference in ER(+/-) groups to some degree yet without statistically significance, while they were significantly different in PR(+/-) groups(P 0.05). Heterozygous genotypes(chr6-32478813, CT and chr6-32470723, GA) were related to breast cancer with PR(-)(OR=0.53, 95% CI: 0.29~0.94; OR=0.44, 95%CI: 0.19~0.99, respectively). Conclusion There is no significant difference between the polymorphism of both chr6-32478813 and chr6-32470723 in gene BTNL2 and susceptibility of breast cancer in Guangdong women of Han Nationality while the heterozygous genotypes are associated with breast cancer tissue with PR(-).
出处 《分子诊断与治疗杂志》 2012年第1期11-15,共5页 Journal of Molecular Diagnostics and Therapy
基金 广州市科技攻关计划(2008A1-E4151)
关键词 BTNL2 乳腺癌 单核苷酸多态性 易感性 BTNL2 Breast cancer Single nucleotide polymorphisms Susceptibility
  • 相关文献

参考文献16

  • 1Ziegler R G, Anderson W F, Gail M H. Increasing breast cancer incidence in China: the numbers add up[J]. J Natl Cancer Inst, 2008, 100(19): 1339-1341.
  • 2王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 3朱秀芬,张莉梅,姜海洋,刘香华.大连市区1991~2005年乳腺癌流行趋势分析[J].疾病监测与控制,2008,2(8):458-459. 被引量:3
  • 4张嘉庆,程琳.家族性乳腺癌的研究现状[J].中华肿瘤防治杂志,2006,13(16):1201-1204. 被引量:6
  • 5Arnett H A, Escobar S S, Gonzalez-Suarez E, et al. BTNL2, a butyrophilin/B7-1ike molecule, is a negative costimulatory molecule modulated in intestinal inflammation[J]. J Immunol, 2007, 178(3): 1523-33.
  • 6Nguyen T, Liu X K, Zhang Y, et al. BTNL2, a butyrophilinlike molecule that functions to inhibit T cell activation[J]. J Immunol, 2006, 176(12): 7354-7360.
  • 7Ogg S L, Weldon A K, Dobbie L, et al. Expression of butyrophilin(Btnl a 1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets[J]. Proc Natl Acad Sci USA, 2004, 101(27): 10084-10089.
  • 8Mana P, Goodyear M, Bemard C, et al. Tolerance induction by molecular mimicry: prevention and suppression of experimental autoimmune encephalomyelitis with the milk protein butyrophilin[J]. Int Immunol, 2004, 16(3): 489-499.
  • 9Linsley P S, Peach R, Gladstone P, et al. Extending the B7 (CD80) gene family[J]. Protein Sci, 1994, 3(8): 1341-1343.
  • 10Pathan S, Gowdy R E, Cooney R, et al. Confirmation of the novel association at the BTNL2 locus with ulcerative colitis[J]. Tissue Antigens, 2009, 74(4): 322-329.

二级参考文献35

  • 1王启俊,祝伟星,邢秀梅.北京市恶性肿瘤流行趋势分析[J].实用肿瘤学杂志,1993,7(3):7-9. 被引量:6
  • 2Vogel V G, Costantino J P, Wickerham D L,et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene(STAR) P-2 trial[J].JAMA, 2006, 295(23):2727-2741.
  • 3Newman L A, Kuerer H M, Hung K K, et al. Prophylactic mastectomy[J].J Am Coll Surg,2000,191(3) :322-330.
  • 4Rebbeck T R, Friebel T, Lynch H T, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group[J].J Clin Oncol,2004,22(6), 1055-1062.
  • 5Eisen A, Rebbeck T R, Wood W C, et al. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer[J].J Clin Oncol, 2000,18(9):1980-1995.
  • 6Xu X, Wagner K U, Larson D, et al. Conditional mutation of Brcal in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation[J]. Nat Genet,1999,22(1):37-43.
  • 7Deng C X, Scott F. Role of the tumor ,suppressor gene Brcal in genetic stability and mammary gland tumor formation[J]. Oncogene, 2000, 19(8) : 1059- 1064.
  • 8Staff S, Isola J, Tanner M. Haplo-insufficiency of BRCA1 in sporadic breast cancer[J].Cancer Res,2003,63(16):4978-4983.
  • 9Hughes-Davies L, Huntsman D, Ruas M, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer[J].Cell,2003, 115(5):523-535.
  • 10Birch J M, Blair V, Kelsey A M, et al. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome[J].Oncogene, 1998, 17(9): 1061-1068.

共引文献87

同被引文献36

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA CancerJ Clin, 2011, 61 (2):69-90.
  • 2Linos E, Spanos D, Rosner BA, et al. Effects of reproductive and de- mographic changes on breast cancer incidence in China: a model- ing analysis[J].J Nad Cancer Inst, 2008, 100(19):1352-1360.
  • 3Ziegler RG, Anderson X,V-F, Gall M.H. Increasing breast cancer inci- dence in China: the numbers add up[J]. J Nad Cancer Inst, 2008, 100(19):1339-1341.
  • 4Trowsdale J. The MHC, disease and selection[J]. Immunol Lett, 2011, 137(1-2):1-8.
  • 5Tsai S, Santamaria P. MHC Class lI Polymorphisms, Autoreacfive T--Cells, and Autoimmunity[J]. Front Immunol, 2013, 4(10):321.
  • 6Bhutia SK, Mallick SK, Maiti TK. Tumour escape mechanisms and their therapeutic implications in combination tumour therapy[J]. Cell Biol Int, 2010, 34(5):553-563.
  • 7Ghaderi A, Talei A, Gharesi-Fard B, et al. HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer[J]. Pathol Oncol Res, 2001, 7(1):39--41.
  • 8Lavado R, Benavides M, Villar E, et al. The HLA-B7 allele confers susceptibility to breast cancer in Spanish women[J]. Immunol Lett, 2005, 101(2):223--225.
  • 9Baccar Harrath A, Yacoubi Loueslati B, Troudi W, et al. HI.,A class lI polymo.
  • 10rphism: protective or risk factors to breast cancer in Tu- nisia[J]? Pathol Oncol Res, 2006, 12(2):79--81.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部